Prescription Medicines Code of Practice Authority (PMCPA)

#Association of the British Pharmaceutical Industry #Daiichi Sankyo #Prescription Medicines Code of Practice Authority (PMCPA) #Teva

Teva and Daiichi Sankyo found in breach of the UK ABPI Code

Both Teva and Daichi Sankyo have been found to be in breach of the Association of the British Pharmaceutical Industry (ABPI) Code of Practice by the Prescription Medicines Code of Practice Authority (PMCPA). Teva was ruled in breach of several clauses of the 2019 Code for… Read More

#News

#ABPI #AstraZeneca #Daiichi Sankyo #LEO Pharma #Prescription Medicines Code of Practice Authority (PMCPA) #Regulatory

Pharma watchdog calls out Leo, AZ and Daiichi Sankyo for misleading ads 

The Prescription Medicines Code of Practice Authority (PMCPA), a self-regulatory body which administers the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry, have opened cases against Leo Pharma, AstraZeneca and Daiichi Sankyo for bringing discredit upon, and reducing confidence in, the pharmaceutical industry. AstraZeneca  … Read More

#News #Regulatory